Business Wire

PubMatic Empowers Publishers to Reclaim Control of Ad Decisioning

Del

PubMatic, the marketing automation software company for publishers, today announced the launch of the market’s first enterprise-grade wrapper solution for publishers that solves for the current inefficiencies in header tag management and measurement. The new wrapper solution is available to publishers free of charge backed by full technical support and analytics.

Unlike other offerings, PubMatic’s complete wrapper solution enables the holistic management of all header bidding partners and provides a transparent, real-time view into bid activity and volume, monetization and latency metrics. PubMatic is working with more than twelve publishers in North America and Europe on this new wrapper solution.

Existing wrapper tags are complicated and require extensive resources for integration. As compared to other wrapper offerings in market, PubMatic’s wrapper solution reduces integration time by up to 80 percent, which is critical to publishers with limited technical resources. Prior, publishers needed to rely on engineering teams for tag management and integration. Now, publishers can easily configure and measure all of their header bidders through a powerful, intuitive user interface. PubMatic’s solution allows publishers to focus on their business and leave the tactical work to an experienced technology partner.

“Programmatic is the future of digital advertising, and header bidding is a critical part of how we get there,” said Lars Näslund, head of data and programmatic at Egmont, one of the largest media companies in Europe. “We’re working closely with PubMatic to not only take back control of our inventory management capabilities, but also determine accurate ‘market prices’ for our inventory, effectively resetting the digital currency as we know it.”

PubMatic’s wrapper solution solves for common inefficiencies in ad serving, drives sustainable monetization and allows publishers to make smarter decisions, including:

  • Streamlined Integration: Publishers can manage their header bidding tags easily and efficiently, eliminating difficult integrations by reducing the need to implement each header bidding tag separately. Ad operations teams are able to regain control of the ad decisioning process without having to rely on engineering teams for long, arduous integrations that require significant manual work.
  • Intuitive Powerful UI: The rich user interface allows publishers to move beyond the back-end coding and workarounds found in current offerings. The PubMatic UI provides greater control over demand sources for the publisher. Granular controls allow publishers to block high latency and low performing partners from bidding, helping to maximize revenue on each impression. In addition, publishers can easily implement customized page-level latency settings based on consumers’ expectations.
  • Enterprise Grade Analytics: The real-time analytics and reporting platform enables a holistic view of a publisher’s header bidding partners, with a detailed analysis of metrics around volume, latency and monetization including bid rates, win ratios, and average CPMs, in an easy-to-access dashboard allowing for easy testing and optimization. These detailed insights allow publishers to identify their strongest header tags based on performance.

“Currently, publishers are going through unnecessarily complicated integrations that don’t provide all of the tools required to manage and understand the performance of their header bidding partners,” said Evan Simeone, Vice President, Product Management at PubMatic. “A complete wrapper solution—as opposed to just a tag— provides publishers with a unified view of their programmatic demand placing it on equal footing with their direct sales.”

PubMatic is focused on driving innovation and monetization for the premium publisher segment. Its wrapper solution is a step forward in the evolution of ad decisioning, as it rapidly approaches a holistic monetization platform for publishers, providing inventory management, real-time reporting and analytics tools and ad serving. The company is building the next generation of marketing automation products for the increasingly digital world.

About PubMatic

PubMatic is the leading marketing automation software company for publishers. Through real-time analytics, yield management, and workflow automation, PubMatic enables publishers to make smarter inventory decisions and improve revenue performance. Focused on serving the needs of premium publishers, PubMatic inspires buyer confidence by providing flexibility in audience discovery and planning media campaigns through its Media Buyer Console and APIs. The company’s marketing automation software platform provides a global roster of comScore publishers with a single view into their advertiser relationships across every screen, every channel and every format. PubMatic was ranked by Deloitte as one of the fastest growing companies in the U.S. Internet sector for the fourth consecutive year in 2015. The company has offices worldwide, and is headquartered in Redwood City, California.

PubMatic is a registered trademark of PubMatic, Inc. Other trademarks are the property of their respective owners.

Contact information

Global Contact:
PubMatic
Nicole Kapner, 516-343-9134
Manager, Corporate Communications
Nicole.Kapner@pubmatic.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Kite Announces Data From ZUMA-3 Study of KTE-C19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia12.12.2017 00:30Pressemelding

Kite, a Gilead Company (Nasdaq: GILD), announced updated results from the ongoing Phase 1/2 ZUMA-3 study of KTE-C19, a CD19 chimeric antigen receptor T (CAR T) cell therapy, which is investigational for the treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL). With a minimum of eight weeks of follow-up, 71 percent of ALL patients (n=17/24) who received a single infusion of KTE-C19 achieved complete tumor remission (complete remission (CR) or CR with incomplete hematological recovery). The ZUMA-3 study results were presented in an oral session at the Annual Meeting of the American Society of Hematology (ASH) in Atlanta. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005311/en/ ALL is an aggressive type of blood cancer which can also involve the lymph nodes, spleen, liver, central

NTT Communications Strengthens its DDoS Protection Services with New Detection Solution11.12.2017 23:00Pressemelding

NTT Communications Corporation (NTT Com), the global data and IP services arm of Fortune Global 500 telecom leader NTT (TYO: 9432), announced that it is expanding its Distributed Denial of Service Protection Services (DPS) with the addition of DPS Detect. This new solution can help customers detect potential attacks directed to their networks and initiate mitigations faster. DDoS attacks can strike at any time, potentially crippling network infrastructure and severely degrading the performance and reachability of a website or other IP-accessible assets. The expanded DPS suite of services will enable Global IP Network customers around the world to easily customize the level of service and assistance that best fits their needs. “Network security is one of the top priorities for our company,” said Michael Wheeler, executive vice president of the NTT Communications

Interactive Brokers Launches Bitcoin Futures Trading at the Start of Trading December 10th, 201711.12.2017 16:28Pressemelding

Interactive Brokers Group, Inc. (NASDAQ GS:IBKR), a global electronic brokerage firm, began offering clients the ability to trade bitcoin futures at the start of trading on the Cboe Futures Exchange (CFE) on Sunday night, December 10th, 2017. In addition to offering bitcoin futures from the CFE, under the ticker symbol GXBT, the company plans to offer bitcoin futures from the Chicago Mercantile Exchange (CME) at the scheduled start of trading December 18th using the symbol BRR. IBKR was there at the start of trading and its systems operated normally. “Interactive Brokers was on the buy side of the low print of 14,710,” said Thomas Peterffy, founder, Chairman and CEO of Interactive Brokers. “A Registered Investment Advisor on the Interactive Brokers platform purchased two March contracts in the first minute of trading.” As of 9:15am ET on Monday, the company said that

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 201711.12.2017 13:00Pressemelding

2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against cancer. External partnerships complement Boehringer Ingelheim’s two-pronged research strategy – investigating both cancer cell-directed therapies and immune cell-directed therapies. This multi-faceted approach offers the potential to bring innovative opportunities to the Boehringer Ingelheim oncology portfolio and novel therapies to patients. “Immuno-oncology is radically shifting the research and treatment landscape in oncology. We believe that the greatest success in difficult-to-treat cancers will be achieved with immuno-oncology and its combination with cancer cell directed therapy, which is why we are committing significant resources in both areas,” said Jonathon Sedgwick, Ph.D., Vice

Valence Advises SK Capital on Its Acquisition of ICL’s Fire Safety and Oil Additives Businesses11.12.2017 12:47Pressemelding

The Valence Group acted as lead financial advisor to SK Capital Partners on its announced acquisition of the Fire Safety and Oil Additives businesses of Israel Chemicals Ltd. (“ICL”) for approximately $1 billion. The transaction is expected to close during the first half of 2018. The Businesses, headquartered in St. Louis, Missouri, have global operations and are market leaders in each of their segments. The ICL Fire Safety business is a formulator and manufacturer of fire management chemicals. Its Phos-Chek fire retardants, Class A and B foams, and water enhancing gels are the world’s leading chemical solutions for managing wildland, military, industrial and municipal fires, and are used in partnership with fire management agencies across the globe. The ICL Oil Additives business provides high quality phosphorus pentasulfide used in the preparation of ZDDP-based lubricant additives, i

Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care11.12.2017 10:18Pressemelding

Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the European launch of MolecuLight i:X TM, the easy to use, handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of potentially harmful bacteria in wounds.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005434/en/ Currently wound assessments are made with the naked eye which can lack the accuracy required to most effectively guide clinical decision making.4 Using fluorescence, MolecuLight i:X quickly, safely, and easily visualises potentially harmful bacteria1,2,3 in wounds which may otherwise lack signs or symptoms of infection. It enhances a clinician’s ability to choose the right therapy, at the right time for their patient1,

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom